NCT06319209View on ClinicalTrials.gov

Timing of Surgery and the Evolution of Postoperative Outcomes in Breast Cancer Patients Undergoing Surgical Intervention Following Recovery From SARS-CoV-2 Infection

Active, not recruitingOBSERVATIONAL
Enrollment

392

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2024

Conditions
Breast CancerCOVID-19Postoperative Complications
Interventions
OTHER

Preoperative resolved COVID-19

We observed postoperative outcomes only in patients who had or did not have COVID-19 before surgery, without any additional intervention.

Trial Locations (1)

Unknown

Fujian Medical University Union Hospital, Fuzhou

All Listed Sponsors
lead

Fujian Medical University Union Hospital

OTHER